This question is arising as those patients with asymptomatic, mild or moderate COVID-19 are recovering. Is the degree of immunity dependent on:
1. Severity of the disease
2. IgG titer in the recovered patients
These question becomes more relevant because until a vaccine for the 2019-nCoV is available, convalescent patient sera can be used to improve the immunity in early stage of COVID-19, as was used with success in the treatment of several Ebola patients during the outbreak in 2014–2015.